Fluvastatin vs pravastatin in treating hyperlipidemia
He Xiao
Abstract
He Xiao
Abstract
AIM: To observe and compare the antihyperlipidemia efficacy of fluvastatin vs pravasatin. METHODS: Fluvastatin group( n =41,M 22, F 19; age 60 a± s 8 a) was treated with fluvastatin 20 40 mg, po , qn for 4 wk. Pravastatin group( n =35, M 20, F 15; age 60 a±6 a) was treated with pravastatin 10 mg, po , qn for 4 wk. RESULTS: The total effective rate of fluvastatin for reducing TC was 92 %, it was higher than that of pravastatin 70 %( P 0.05). The total effective rates of flavastatin for reducing TG and raising HDL C were 61 % and 61 %, were similar to that of pravastatin 73 % and 69 %( P 0.05). Adverse reactions occurred in 8 patients of fluvastatin(20 %) and in 7 patients of pravastatin(20 %), but were mild in both groups. CONCLUSION: Fluvastatin is a safe and effective antihyperlipidemic drug, and fluvastatin is more effective than pravastatin in decreasing total cholesterol.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To observe and compare the antihyperlipidemia efficacy of fluvastatin vs pravasatin. METHODS: Fluvastatin group( n =41,M 22, F 19; age 60 a± s 8 a) was treated with fluvastatin 20 40 mg, po , qn for 4 wk. Pravastatin group( n =35, M 20, F 15; age 60 a±6 a) was treated with pravastatin 10 mg, po , qn for 4 wk. RESULTS: The total effective rate of fluvastatin for reducing TC was 92 %, it was higher than that of pravastatin 70 %( P 0.05). The total effective rates of flavastatin for reducing TG and raising HDL C were 61 % and 61 %, were similar to that of pravastatin 73 % and 69 %( P 0.05). Adverse reactions occurred in 8 patients of fluvastatin(20 %) and in 7 patients of pravastatin(20 %), but were mild in both groups. CONCLUSION: Fluvastatin is a safe and effective antihyperlipidemic drug, and fluvastatin is more effective than pravastatin in decreasing total cholesterol.
Key concepts: Pravastatin, Fluvastatin, Hyperlipidemia, Medicine, Statin, Pharmacology, Adverse effect, Internal medicine